60 μg Hepatitis B Vaccine
Hepatitis B Relapse Prevention
Clinical TrialApproved for Trial
Key Facts
Indication
Hepatitis B Relapse Prevention
Phase
Clinical Trial
Status
Approved for Trial
Company
About Kangtai Biological Products
A leading Chinese vaccine developer and manufacturer with a broad infectious disease portfolio and significant international expansion.
View full company profile